Answers are grounded in this paper and cite their sources.
Bacterial pneumonia constitutes a major threat to the healthy development of animal husbandry and public health security. The escalating prevalence of bacterial drug resistance has exacerbated challenges in the prevention and treatment of this disease, creating an urgent need for novel therapeutic strategies. Carbon dots (CDots) synthesized from ascorbic acid and polyethyleneimine, as well as miR-21–5p derived from porcine tracheal epithelial cells, have been shown to individually exert protective effects against pulmonary bacterial infections. However, their combined therapeutic efficacy and underlying mechanisms remain unclear. Herein, we established an in vitro infection model using alveolar macrophages infected with Actinobacillus pleuropneumoniae (APP), a pathogen that causes typical pleurisy and pneumonia and is frequently used as a model strain in bacterial pneumonia research. We found that treatment with CDots and miR-21–5p enhanced the phagocytic and bactericidal activities of alveolar macrophages against APP, while simultaneously inhibiting APP-induced pyroptosis in these cells. Mechanistically, APP infection activated the PI3K/AKT signaling pathway, whereas CDots and miR-21–5p abrogated this activation, thereby mitigating macrophage pyroptosis triggered by APP infection. Furthermore, in mouse models infected with APP or methicillin-resistant Staphylococcus aureus (MRSA), both monotherapy and combination therapy with CDots and miR-21–5p significantly reduced mortality, weight loss, clinical scores, and pathological damage to lung tissue. Notably, the combined treatment exhibited the most pronounced therapeutic effects. Additionally, this combination strategy reduced the expression of pro-inflammatory factors IL-6 and IL-1β and attenuated neutrophil infiltration in murine lung tissues infected with APP. Thus, our study demonstrates that combined administration of CDots and miR-21–5p enhances resistance to APP infection in mice by inhibiting PI3K/AKT signaling pathway–mediated macrophage pyroptosis, thereby providing novel strategies for the prevention and treatment of APP and other bacterial pneumonias.
No takes yet. Share an insight, caveat, or question.
Wen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: